TSMTF yields 4.84% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 10
Combined, TSMTF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TSMTF + JNJ for your $10,000?
AS Tallinna Sadam provides port services as a landlord type of port in the Republic of Estonia. The company operates through Passenger Harbours, Cargo Harbours, Ferry, and Other segments. It owns, administers, and develops berths, port basins, and the surrounding areas; ensures safe navigation in port waters; and organizes vessel traffic in port basins, as well as leases land to cargo operators. The company owns and operates the Old City Harbor, a passenger harbor and the Old City Marina for recreational vessels located in the center of Tallinn; the cargo harbor in Muuga; the cargo harbor in Paldiski; and the harbor in Saaremaa for receiving cruise ships, pleasure crafts, and cargo vessels. It also offers icebreaking and other offshore support services; and sells electricity and network services, as well as provides ferry services between Estonia's mainland and biggest islands. AS Tallinna Sadam was incorporated in 1996 and is headquartered in Tallinn, the Republic of Estonia.
Full TSMTF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.